CYTR - VIDEO: CytRx Corporation (OTCQB: CYTR)

CytRx Corporation (OTCQB: CYTR), a biopharmaceutical research and development company with expertise in discovering and developing new therapeutics to treat patients with high unmet needs , according to the company’s website (see here: www.cytrx.com). In this SNNLive In-Studio Video Interview, our host spoke with Eric L. Curtis, President and COO of CytRx Corporation, at our studio in Los Angeles, CA, and they discuss the following topics:

- Overview and history of CytRx Corporation

- Out-License deals with Orphazyme, NantCell and Centurion

- How company’s biopharmaceuticals are unique in the marketplace

- Market sizes

- Mr. Curtis’ background

- Growth drivers for 2019

For more information about CytRx Corporation, please visit: www.cytrx.com

The interview may contain forward looking statements about CytRx Corporation. See CytRx Corporation's periodic filings with the Securities and Exchange Commission for more complete information.

Please read our full disclosure here.